Introduction
Homatropine hydrobromide is a synthetic anticholinergic agent used primarily for its mydriatic (pupil-dilating) and cycloplegic (paralysis of the ciliary muscle) effects. It is commonly used in ophthalmic procedures and to relieve spasm of the eye muscles.
Uses
Homatropine hydrobromide is used for:
- Inducing mydriasis (dilation of the pupil) and cycloplegia for diagnostic and therapeutic purposes in ophthalmology.
- Relieving discomfort and spasm associated with eye conditions.
- Preoperative preparation of the eye in surgical procedures.
| Brand Name | Homatropine Hydrobromide |
|---|---|
| Type | |
| Weight | |
| Generic | Homatropine Hydrobromide |
| Manufacturer | |
| Available in | English বাংলা |
Mechanism of Action
Homatropine hydrobromide works by blocking the action of acetylcholine at muscarinic receptors in the eye. This results in the relaxation of the sphincter muscle of the iris, causing pupil dilation (mydriasis), and paralysis of the ciliary muscle, leading to cycloplegia.
How Long Does It Take to Work?
The onset of action for homatropine hydrobromide is typically within 30 to 60 minutes after administration. The peak effect is generally observed within 1 to 2 hours.
Absorption
Homatropine hydrobromide is administered topically as eye drops. Systemic absorption is minimal due to its localized application, but some absorption can occur through the conjunctiva and nasolacrimal duct.
Route of Elimination
The elimination of homatropine hydrobromide is primarily through the urinary tract. The drug and its metabolites are excreted in the urine following systemic absorption.
Dosage
For refraction: Instill two drops in the eye(s) and repeat 2-3 times at 5-10 minute intervals.For therapy: Instill 1-2 drops in the eye(s) every 3-4 hours.
Use in children: Should not be used in children below the age of 3 months.
The standard dosage for ophthalmic use is:
- 1 to 2 drops of a 2% solution instilled into the affected eye(s) 1 to 3 times daily, depending on the specific condition and the physician's instructions.
Dosage may vary based on the clinical situation and patient response.
Administration
Homatropine hydrobromide is administered as an ophthalmic solution. Instill the prescribed number of drops into the conjunctival sac of the eye, being careful not to touch the dropper tip to any surface to avoid contamination.
Side Effects
Common side effects of homatropine hydrobromide include:
- Blurred vision.
- Photophobia (sensitivity to light).
- Stinging or burning sensation in the eye.
Serious side effects can include increased intraocular pressure or allergic reactions.
Toxicity
Systemic toxicity is rare but can occur with excessive use. Symptoms of toxicity may include dry mouth, flushed skin, and fever. Severe toxicity can lead to anticholinergic effects such as confusion or hallucinations.
Precautions
Precautions include:
- Monitoring for adverse effects, especially in patients with a history of narrow-angle glaucoma or other ocular conditions.
- Use with caution in patients with hypersensitivity to anticholinergic drugs.
- Avoid overuse to prevent potential systemic absorption and toxicity.
Interaction
Homatropine hydrobromide may interact with other anticholinergic agents or medications that have similar effects. Caution is advised when used concurrently with other drugs affecting the central nervous system.
Disease Interaction
Use with caution in patients with preexisting conditions such as glaucoma, especially narrow-angle glaucoma, as homatropine can exacerbate these conditions.
Drug Interaction
There is limited evidence of significant drug interactions with homatropine hydrobromide, but concurrent use with other anticholinergic agents should be monitored for additive effects.
Food Interactions
Food interactions are minimal as homatropine hydrobromide is administered topically. There are no specific dietary restrictions associated with its use.
Pregnancy Use
The safety of homatropine hydrobromide during pregnancy has not been well-established. It should be used during pregnancy only if the potential benefit justifies the risk to the fetus.
Lactation Use
It is unknown whether homatropine hydrobromide is excreted in human breast milk. Caution should be exercised when administering to breastfeeding women, and alternative treatments should be considered if needed.
Acute Overdose
Acute overdose is unlikely with ophthalmic administration but can occur if ingested or excessively applied. Treatment involves symptomatic management and supportive care. Systemic symptoms should be managed based on their severity.
Contraindication
Homatropine hydrobromide is contraindicated in patients with:
- Known hypersensitivity to homatropine or other anticholinergic drugs.
- Uncontrolled narrow-angle glaucoma.
Use Direction
Follow the prescribed dosage and administration instructions provided by the healthcare provider. Avoid touching the dropper tip to any surface to maintain sterility.
Storage Conditions
Store homatropine hydrobromide eye drops at room temperature, away from light. Ensure the bottle is tightly closed when not in use.
Volume of Distribution
The volume of distribution for homatropine hydrobromide is not specifically characterized due to its localized application and minimal systemic absorption.
Half Life
The half-life of homatropine hydrobromide is not well-documented due to its local application. Its effects typically last for several hours, depending on the dosage and individual response.
Clearance
Clearance of homatropine hydrobromide is primarily through renal excretion after systemic absorption. The drug is metabolized in the liver and excreted in the urine.
See in details version Homatropine Hydrobromide also Homatropine Hydrobromide in bangla
